Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Legal

Group By Ticker
Sort By
Newest | Oldest
Read More
5 minute read
  • Biotech
  • Economics
  • General
  • Legal
  • Macro Economic Events
  • News

‘Germany Delays Final Vote On Marijuana Legalization Bill Until Next Year’ – Marijuana Moment

By Benzinga Newsdesk
December 4, 3:26 PM
https://www.marijuanamoment.net/germany-delays-final-vote-on-marijuana-legalization-bill-until-next-year/A final vote on a bill to legalize marijuana in Germany that was initially planned for this week has been called

EWG

Read More
1 minute read
  • General
  • Health Care
  • Legal
  • News

Venue Turmoil: Pharma Companies Oppose States’ Bid to Relocate Price-Fixing Cases

By Vandana Singh
December 4, 3:02 PM
Major pharmaceutical firms, including generic manufacturers such as Teva Pharmaceutical Industries Limited (NYSE: TEVA), Sandoz Group (OTC: 

SDZNY

Read More
1 minute read
  • Equities
  • General
  • Health Care
  • Large Cap
  • Legal
  • Markets
  • Media
  • News

Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion

By Vandana Singh
December 4, 2:39 PM
The spotlight is on a Philadelphia trial as Bayer AG (OTC: BAYRY) (OTC: BAYZF) grapples with mounting legal challenges surrounding its Roundup weedkiller, prompted by multi-billion dollar verdicts 

BAYRY

Read More
1 minute read
  • Contracts
  • Legal
  • M&A
  • News

Novo Integrated Sciences’ Purchase And Sale Agreement To Acquire Ophir Collection For $60M Receives Court Approval

By Benzinga Newsdesk
December 4, 12:31 PM
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") today announced the United States District Court for the Central District of California has approved the Purchase and Sale Agreement ("PSA") which

NVOS

Read More
2 minute read
  • General
  • Government
  • Health Care
  • Legal
  • News

Opioid Crisis and Corporate Accountability: Purdue’s Settlement in the Spotlight

By Vandana Singh
December 4, 12:29 PM
The U.S. Supreme Court is reviewing a contentious bankruptcy settlement involving Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family. 

CI

Read More
1 minute read
  • Eurozone
  • Global
  • Legal
  • Markets
  • News

‘The Media Grouped In AMI Sue META For Unfair Competition And Claim More Than €550M’ – AMI

By Benzinga Newsdesk
December 4, 11:32 AM
https://www.ami.info/ami-demanda-a-meta-por-competencia-desleal-y-reclama-mas-de-550-millones.html The Media Association ( AMI ) has filed a lawsuit against META, representing 83 Spanish media, for its systematic

META

Read More
1 minute read
  • Legal
  • News

Delaware Court Of Chancery Rules In Favor Of Texas Pacific Land Corporation On Litigation Related To Stockholders’ Agreement

By Benzinga Newsdesk
December 4, 9:21 AM
Texas Pacific Land Corporation (NYSE:TPL) ("TPL" or the "Company") announced today that the Delaware Court of Chancery (the "Court") has ruled in favor of TPL in the litigation between the Company and Horizon Kinetics

TPL

Read More
2 minute read
  • Cannabis
  • General
  • Health Care
  • Legal
  • Markets
  • News
  • Politics

Supreme Court Decision Looms Over Purdue Pharma’s $6B Opioid Settlement And Sackler Family Immunity

By Maureen Meehan
December 3, 3:33 PM
The fate of a $6 billion bankruptcy settlement involving Purdue Pharma, the maker of the powerful and addictive pain medication OxyContin, hangs in th

JNJ

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy

By Vandana Singh
December 1, 11:59 AM
Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc (NYSE: PFE), alleging the pharmaceutical giant misrepresented the efficacy of its widely-

JNJ

Read More
2 minute read
  • Legal
  • News

‘Attor­ney Gen­er­al Ken Pax­ton Sues Pfiz­er For Mis­rep­re­sent­ing COVID-19 Vac­cine Effi­ca­cy And Con­spir­ing To Cen­sor Pub­lic Discourse’ –

By Benzinga Newsdesk
November 30, 6:39 PM
https://www.texasattorneygeneral.gov/news/releases/attorney-general-ken-paxton-sues-pfizer-misrepresenting-covid-19-vaccine-efficacy-and-conspiring Texas Attorney General Ken Paxton has sued Pfizer, Inc., for

PFE

Posts pagination

Previous 1 … 56 57 58 … 258 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service